ENANTA PHARMACEUTICALS, INC Proceeds from Income Tax Refunds
ENANTA PHARMACEUTICALS, INC (ENTA) reported Proceeds from Income Tax Refunds of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC proceeds from income tax refunds for the quarter ending 2025-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC proceeds from income tax refunds for the quarter ending 2024-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC proceeds from income tax refunds for fiscal 2025 was $33.78M.
- ENANTA PHARMACEUTICALS, INC proceeds from income tax refunds for fiscal 2024 was $0.00.
- ENANTA PHARMACEUTICALS, INC proceeds from income tax refunds for fiscal 2023 was $0.00.
| Period end | Proceeds from Income Tax Refunds 3 month | Proceeds from Income Tax Refunds 9 month | Proceeds from Income Tax Refunds 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | ||
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $33.78M 10-K · filed 2025-11-19 | |
| 2025-06-30 | $33.78M 10-Q · filed 2026-08-12 | ||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $0.00 10-K · filed 2025-11-19 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | ||
| 2023-09-30 | $0.00 10-K · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |